109 Aufrufe 109 0 Kommentare 0 Kommentare

    Paragon 28 to Present at the 43rd Annual J.P. Morgan Healthcare Conference

    Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO and Chadi Chahine, CFO & EVP of Supply Chain Operations, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 7:30 a.m. Pacific Time / 8:30 a.m. Mountain Time.

    A live webcast, as well as the archived recording, will be available on the investor relations section of the Company’s website at ir.paragon28.com.

    About Paragon 28, Inc.

    Based in Englewood, CO., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28 has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.


    The Paragon 28 Stock at the time of publication of the news with a raise of +8,25 % to 10,50EUR on Tradegate stock exchange (02. Januar 2025, 22:27 Uhr).



    Business Wire (engl.)
    0 Follower
    Autor folgen

    Paragon 28 to Present at the 43rd Annual J.P. Morgan Healthcare Conference Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO and Chadi Chahine, CFO & EVP of Supply Chain Operations, will present …